{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-098293","form_type":"8-K","ticker":null,"cik":"0001798270","company_name":"Assure Holdings Corp.","filed_at":"2023-09-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.281172+00:00","generated_at":"2026-06-11T00:06:35.602162+00:00","sec_items":["2.01","3.02","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Assure Holdings completes $1.2M asset acquisition from Innovation Neuromonitoring","bullets":["Total consideration $1.2M: $800k cash (includes $500k in 24 monthly installments) plus $400k in common stock (547,946 shares).","Shares are restricted with a six-month lock-up; company must file Form S-1 for resale registration within 15 days.","Acquired assets include tangible property, inventory, contracts, IP, and goodwill from Seller's intraoperative neuromonitoring business.","No material existing relationship between Company and Seller outside the Purchase Agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-098293","json":"https://secwatch.observer/filing/0001104659-23-098293.json","markdown":"https://secwatch.observer/filing/0001104659-23-098293.md","text":"https://secwatch.observer/filing/0001104659-23-098293.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1798270/000110465923098293/0001104659-23-098293-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1798270/000110465923098293/tm2324306d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T00:06:35.602162+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5318da988ae23ea5d5289a301d0e886116629e08","claim":"Assure Holdings Corp. completed an acquisition involving Innovation Neuromonitoring LLC for $1,200,000 (closed 2023-08-29).","evidence_excerpt":"records, contracts, licenses, warranties, intellectual property, goodwill, software, (collectively, the “Assets”). The consideration amount under the Purchase Agreement was $1,200,000 (the “Purchase Price”). As previously reported, the Purchase Price was payable as set forth below. (1) $800,000 in cash installment payments, in accordance with the following","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1798270/000110465923098293/0001104659-23-098293-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"Innovation Neuromonitoring LLC"},{"label":"Consideration","value":"$1,200,000"},{"label":"Closing","value":"2023-08-29"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}